Mabonga Emily, Parkes-Ratanshi Rosalind, Riedel Stefan, Nabweyambo Sheila, Mbabazi Olive, Taylor Chris, Gaydos Charlotte, Manabe Yukari C
1 Waldron Sexual Health Centre, Lewisham and Greenwich NHS Trust, London, UK.
2 Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Int J STD AIDS. 2019 Mar;30(3):256-263. doi: 10.1177/0956462418799017. Epub 2018 Nov 4.
Antimicrobial resistance (AMR) to gonorrhoea is a threat to global health security. There have been concerns expressed that countries with high rates of disease have poor surveillance. The objectives of the study were to determine the AMR patterns of Neisseria gonorrhoeae clinical isolates to antimicrobial agents in patients with HIV or high risk of HIV acquisition, to compare the concordance of disk diffusion and agar dilution as methods for determining AMR to N. gonorrhoeae, and to describe methodological challenges to carrying out AMR testing. The study was conducted at an HIV outpatient service for at-risk populations and an outreach clinic for commercial sex workers in Kampala. Patients were offered a sexually transmitted infection screen using a polymerase chain reaction (PCR)-based assay. Samples positive for gonorrhoea were cultured. Antimicrobial susceptibility testing was performed using disk diffusion and isolates were sent to a reference laboratory for agar dilution direct susceptibility testing. Five hundred and seventy-five patients were screened. There were 33 (5.7%) patients with gonorrhoea detected by PCR. Of the 16 viable N. gonorrhoeae isolates, 100% were resistant to ciprofloxacin and tetracycline by disk diffusion and 31% exhibited reduced susceptibility to ceftriaxone and cefixime. By agar dilution, 100% of isolates were resistant to ciprofloxacin and all isolates were susceptible to ceftriaxone and cefixime. There was concordance between disk diffusion and agar dilution for ciprofloxacin and tetracycline resistance and a significant discordance for third-generation cephalosporins. More than half the women with gonorrhoea were asymptomatic and represent a potential reservoir for ongoing transmission. AMR testing of N. gonorrhoeae isolates is needed to ensure optimal treatment and prevention of antibiotic resistance progression.
淋病的抗菌药物耐药性(AMR)对全球卫生安全构成威胁。有人担心疾病发病率高的国家监测不力。本研究的目的是确定淋病奈瑟菌临床分离株对艾滋病毒感染者或有感染艾滋病毒高风险患者的抗菌药物的AMR模式,比较纸片扩散法和琼脂稀释法作为测定淋病奈瑟菌AMR方法的一致性,并描述开展AMR检测的方法学挑战。该研究在坎帕拉一家针对高危人群的艾滋病毒门诊服务机构和一家商业性工作者外展诊所进行。为患者提供了基于聚合酶链反应(PCR)检测的性传播感染筛查。淋病检测呈阳性的样本进行培养。采用纸片扩散法进行抗菌药物敏感性试验,并将分离株送至参考实验室进行琼脂稀释直接药敏试验。共筛查了575名患者。通过PCR检测出33名(5.7%)淋病患者。在16株可培养的淋病奈瑟菌分离株中,纸片扩散法检测显示100%对环丙沙星和四环素耐药,31%对头孢曲松和头孢克肟敏感性降低。琼脂稀释法检测显示,100%的分离株对环丙沙星耐药,所有分离株对头孢曲松和头孢克肟敏感。纸片扩散法和琼脂稀释法在环丙沙星和四环素耐药性检测方面结果一致,但在第三代头孢菌素检测方面存在显著差异。超过一半的淋病女性无症状,是持续传播的潜在传染源。需要对淋病奈瑟菌分离株进行AMR检测,以确保最佳治疗并预防抗生素耐药性的进展。